{"id":624107,"title":"Subsection 56(1) class exemption for practitioners, agents, pharmacists, persons in charge of a hospital, hospital employees, and licensed dealers to conduct activities with psilocybin and MDMA in relation to a special access program authorization - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-26","captureTimestamp":"2026-02-26T22:09:35.997000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/policy-regulations/policy-documents/subsection-56-1-class-exemption-conducting-activities-psilocybin-mdma-special-access-program-authorization.html","snippet":"Subsection 56(1) class exemption for practitioners, agents, pharmacists, persons in charge of a hospital, hospital employees, and licensed dealers to conduct activities with psilocybin and MDMA in relation to a special access program authorization This class exemption will be…","rawSnapshotUrl":"/api/snapshots/raw/624107","browseUrl":"https://replay.healtharchive.ca/job-6/20260226220935/https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/policy-regulations/policy-documents/subsection-56-1-class-exemption-conducting-activities-psilocybin-mdma-special-access-program-authorization.html#ha_snapshot=624107","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}